A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol

被引：0
作者：
Tetsuhiko Asao
Satoshi Watanabe
Takahiro Tanaka
Satoshi Morita
Kunihiko Kobayashi
机构：
[1] Juntendo University Graduate School of Medicine,Department of Respiratory Medicine
[2] Niigata University Graduate School of Medical and Dental Sciences,Department of Respiratory Medicine and Infectious Diseases
[3] Niigata University Medical and Dental Hospital,Clinical and Translational Research Center
[4] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
[5] Saitama Medical University International Medical Center,Department of Respiratory Medicine
来源：
BMC Cancer | / 22卷
关键词：
Small-cell lung cancer; Poor performance status; Immune checkpoint inhibitor; Anti-PD-L1; Durvalumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 49 条
[11]  
Nishiwaki Y(2018)First-line Atezolizumab plus chemotherapy in extensive-stage small-cell lung Cancer N Engl J Med 379 2220-2229
[12]  
Kawahara M(2020)ECOG performance status ≥2 as a prognostic factor in patients with advanced non small cell lung cancer treated with immune checkpoint inhibitors-a systematic review and meta-analysis of real world data Lung Cancer 145 95-104
[13]  
Roth BJ(2019)Baseline tumor size and survival outcomes in lung cancer patients treated with immune checkpoint inhibitors Semin Oncol 46 380-384
[14]  
Johnson DH(undefined)undefined undefined undefined undefined-undefined
[15]  
Einhorn LH(undefined)undefined undefined undefined undefined-undefined
[16]  
Hanna N(undefined)undefined undefined undefined undefined-undefined
[17]  
Bunn PA(undefined)undefined undefined undefined undefined-undefined
[18]  
Langer C(undefined)undefined undefined undefined undefined-undefined
[19]  
Lara PN(undefined)undefined undefined undefined undefined-undefined
[20]  
Natale R(undefined)undefined undefined undefined undefined-undefined
12345